ScoreWhy is Sichuan Huiyu Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -17.08% and Operating profit at -85.54% over the last 5 years
2
Negative results in Mar 25
- NET PROFIT(HY) At CNY 35.36 MM has Grown at -61.46%
- INTEREST(9M) At CNY 7.2 MM has Grown at 10.39%
- NET SALES(Q) At CNY 237.83 MM has Fallen at -12.44%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sichuan Huiyu Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sichuan Huiyu Pharmaceutical Co., Ltd.
-100.0%
0.82
58.04%
China Shanghai Composite
24.27%
1.73
14.05%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-17.08%
EBIT Growth (5y)
-85.54%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
0.24
Tax Ratio
8.98%
Dividend Payout Ratio
60.08%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.75%
ROE (avg)
5.57%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
112
Industry P/E
Price to Book Value
2.87
EV to EBIT
8564.80
EV to EBITDA
93.84
EV to Capital Employed
5.24
EV to Sales
8.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.05%
ROE (Latest)
2.57%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 251.38 MM
NET PROFIT(Q)
At CNY 56.22 MM has Grown at 116.21%
RAW MATERIAL COST(Y)
Fallen by -5.44% (YoY
-11What is not working for the Company
NET PROFIT(HY)
At CNY 35.36 MM has Grown at -61.46%
INTEREST(9M)
At CNY 7.2 MM has Grown at 10.39%
NET SALES(Q)
At CNY 237.83 MM has Fallen at -12.44%
EPS(Q)
Lowest at CNY -0.06
Here's what is working for Sichuan Huiyu Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 251.38 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Profit
At CNY 56.22 MM has Grown at 116.21%
over average net sales of the previous four periods of CNY 26 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Raw Material Cost
Fallen by -5.44% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Sichuan Huiyu Pharmaceutical Co., Ltd.
Net Sales
At CNY 237.83 MM has Fallen at -12.44%
over average net sales of the previous four periods of CNY 271.62 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Interest
At CNY 7.2 MM has Grown at 10.39%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
Lowest at CNY 237.83 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
EPS
Lowest at CNY -0.06
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
